Cardiovascular risk factors and disease in general practice: results of the Nijmegen Cohort Study

J C Bakx1, H J M Van den Hoogen, W J H M Van den Bosch

  • 1Department of General Practice, University of Nijmegen, The Netherlands.

Insights

Cardiovascular disease (CVD) risk factors like high blood pressure and smoking significantly increase risk in men. While risk factors are linked in women, their low absolute CVD risk suggests caution in treatment.

Area of Science:

  • Epidemiology
  • Cardiovascular Medicine
  • Public Health

Background:

  • Cardiovascular disease (CVD) remains a leading cause of mortality worldwide.
  • Identifying and quantifying the impact of various risk factors is crucial for effective prevention strategies.

Purpose of the Study:

  • To determine the relationship between established cardiovascular risk factors and subsequent CVD incidence and mortality.
  • To analyze these relationships separately in men and women within a large prospective cohort.

Main Methods:

  • Utilized data from the Nijmegen Cohort Study, an 18-year prospective investigation.
  • Measured cardiovascular risk factors (age, smoking, cholesterol, blood pressure, BMI, family history) in 7092 participants.
  • Correlated risk factor presence with CVD morbidity and mortality outcomes.

Main Results:

  • A significant association between risk factors and CVD was demonstrated in both sexes.
  • In men, high blood pressure, smoking, and positive family history each conferred a relative risk (RR) of 1.8 for CVD.
  • The cumulative effect of risk factors substantially increased CVD risk; 38% of men with all factors experienced CVD within 18 years.

Conclusions:

  • Established cardiovascular risk factors are strongly associated with CVD morbidity and mortality, particularly in men.
  • The low absolute risk of CVD in women suggests a need for careful consideration regarding the intensity of risk factor treatment in this population.

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...